The effect of Landiolol hydrochloride administrated in the perioperative period of off-pump coronary artery bypass graft surgery on prevention of atrial fibrillation or atrial flutter - JL-KNIGHT study II (Japan Landiolol-Kicking off the novel investigation for gold standard heart study II)

The Society of Clinical Peri-operative Circulation Management0 个研究点目标入组 520 人开始时间: 2013年5月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with acute myocardial infarction occurred within 3 days after getting informed consent 2) Patients with history of atrial fibrillation or atrial flutter (including paroxysmal atrial fibrillation or atrial flutter) 3) Patients who will have any emergency operations within 24 hours after the hospital visits 4) Patients with cardiac shock 5) Patients with diabetic keto-acidosis or metabolic acidosis 6) Patients with bradyarrhythmias (sick sinus syndrome or second or third degree atrioventricular block) 7) Patients with pulmonary arterial hypertension complicating right heart failure 8) Patients with severe heart failure (NYHA functional classification is greater than grade three or ejection fraction is less than 35%) 9) Patients or suspected persons with untreated pheochromocytoma 10) Pregnant women or women with breast-feeding or patients who have possibilities of pregnancy 11) Patients with bronchial asthma or chronic lung diseases 12) Patients with past history of drug hypersensitivity against Landiolol 13) Patients who are judged by the investigators to be inappropriate for this study

发起方

The Society of Clinical Peri-operative Circulation Management